Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A recombinant adenoviral vector encoding functional vasoactive intestinal peptide.

B M Lodde1, C Delporte, C M Goldsmith

  • 1Gene Therapy and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, DHHS, Bethesda, MD 20892-1190, USA. blodde@dir.nidr.nih.gov

Biochemical and Biophysical Research Communications
|May 26, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Displaced Leptons in sqrt[s]=13  TeV pp Collisions with the ATLAS Detector.

Physical review letters·2021
Same author

Longitudinal Flow Decorrelations in Xe+Xe Collisions at sqrt[s_{NN}]=5.44  TeV with the ATLAS Detector.

Physical review letters·2021
Same author

Search for Dark Matter Produced in Association with a Dark Higgs Boson Decaying into W^{±}W^{∓} or ZZ in Fully Hadronic Final States from sqrt[s]=13  TeV pp Collisions Recorded with the ATLAS Detector.

Physical review letters·2021
Same author

Medium-Induced Modification of Z-Tagged Charged Particle Yields in Pb+Pb Collisions at 5.02 TeV with the ATLAS Detector.

Physical review letters·2021
Same author

Observation and Measurement of Forward Proton Scattering in Association with Lepton Pairs Produced via the Photon Fusion Mechanism at ATLAS.

Physical review letters·2021
Same author

Search for Heavy Resonances Decaying into a Photon and a Hadronically Decaying Higgs Boson in pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2021

Researchers developed a novel viral vector to express functional Vasoactive Intestinal Peptide (VIP). This breakthrough enables VIP expression for potential autoimmune disease management.

Area of Science:

  • Neuroendocrinology
  • Molecular Biology
  • Immunology

Background:

  • Vasoactive intestinal peptide (VIP) is a neuropeptide with diverse functions, including immunomodulatory, secretory, and trophic effects.
  • VIP's properties make it a promising candidate for managing autoimmune diseases.

Purpose of the Study:

  • To develop a recombinant viral vector for expressing functional VIP.
  • To assess the biological activity of VIP produced by the viral vector.

Main Methods:

  • Construction of the recombinant adenovirus type 5 vector, rAd5CMVhVIP.
  • Infection of 293 cells with the vector.
  • Measurement of VIP expression using ELISA.
  • Evaluation of VIP function via intracellular cAMP level determination.

Related Experiment Videos

Main Results:

  • The rAd5CMVhVIP vector successfully directed VIP expression in 293 cells.
  • Transgenic VIP induced a dose-dependent increase in intracellular cAMP.
  • This effect was mediated through the VIP receptor VPAC(1).

Conclusions:

  • This study reports the first successful construction of a recombinant viral vector encoding biologically active VIP.
  • The developed vector holds potential for therapeutic applications, particularly in autoimmune disease management.